✦ LIBER ✦

First-line erlotinib shows promising activity in NSCLC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Larotaxel + cisplatin combo shows first-

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Beyond first-line NSCLC therapy: chemoth

✍ Luis Paz-Ares 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 73 KB

Gefitinib shows promise in NSCLC

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 201 KB

Bevacizumab + erlotinib active in NSCLC

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Telavancin shows promising activity in c

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Vx 001 vaccine shows promise in advanced

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB